Monthly Costs: Wegovy vs Mounjaro Price Analysis
Understanding How to Switch From Wegovy to Mounjaro: Monthly Cost Implications
When exploring how to switch from Wegovy to Mounjaro, monthly cost becomes a crucial factor in your long-term weight management journey. Wegovy (semaglutide) operates as a single GLP-1 receptor agonist, while Mounjaro (tirzepatide) functions as a dual GIP and GLP-1 receptor agonist. At EverydayMeds, we provide transparent pricing for both treatments, allowing you to make an informed financial decision alongside your clinical assessment.
The monthly cost difference between these prescription-only medicines can vary significantly across different dose levels. While Wegovy follows a structured 16-week dose escalation from £79.99 monthly, Mounjaro pricing reflects its newer dual-action formulation. Both medications require ongoing monthly investment, making cost comparison essential for sustainable treatment. Our GPhC-registered pharmacy (#9012878) ensures you receive genuine medications with competitive UK pricing for both options.
Wegovy Monthly Pricing Structure When Switching From Mounjaro
Understanding Wegovy's monthly costs helps clarify why many patients consider how to switch from Wegovy to Mounjaro or vice versa. Wegovy begins at £79.99 monthly for the 0.25mg starter dose (weeks 1-4), progressing to £94.99 for 0.5mg (weeks 5-8), then £99.99 for 1mg (weeks 9-12). The dose escalates to £139.99 for 1.7mg (weeks 13-16) before reaching the maintenance dose of 2.4mg at £209.99 monthly. New customers benefit from our FIRST40 discount code applied at checkout to reach these final prices.
For returning customers wondering how to switch from Wegovy to Mounjaro cost-effectively, our DOSE25 discount code ensures ongoing value. Bundle options provide convenience rather than savings, such as our Ultimate Stability Trio offering three months of 2.4mg maintenance supply for £649.99. This pricing transparency allows direct comparison with Mounjaro's cost structure when making switching decisions alongside your prescriber's guidance.
Clinical Evidence Supporting How to Switch From Wegovy to Mounjaro Decisions
The STEP clinical trials demonstrate Wegovy's efficacy, with patients achieving approximately 15% average weight loss at 68 weeks when combined with diet and exercise (Wilding et al., NEJM, 2021). Meanwhile, Mounjaro's SURMOUNT trials show its dual-action mechanism may offer different efficacy profiles. When considering how to switch from Wegovy to Mounjaro, these clinical outcomes help justify the monthly investment in either treatment.
Both medications represent significant advances in prescription weight management, though monthly costs may influence long-term adherence. The SELECT trial further demonstrated Wegovy's cardiovascular benefits, showing a 20% reduction in major cardiovascular events. These clinical benefits help contextualise the monthly prescription costs when evaluating how to switch from Wegovy to Mounjaro based on both efficacy and affordability.
Wegovy's Mechanism: Understanding What You're Paying For Monthly
Wegovy functions as a GLP-1 receptor agonist, mimicking your body's natural incretin hormones to reduce appetite and promote satiety after smaller meals. This once-weekly injectable prescription-only medicine works on brain appetite centres, potentially reducing food cravings throughout the month. The monthly cost reflects this sophisticated mechanism that supports sustainable weight management when combined with a reduced-calorie diet and increased physical activity. Unlike daily medications, Wegovy's weekly dosing schedule means your monthly cost covers four precise doses delivered via the FlexTouch pen system. Understanding this mechanism helps justify the monthly investment, whether you're starting Wegovy or considering how to switch from Wegovy to Mounjaro for different therapeutic benefits.
Ordering Process for Switching From Wegovy to Mounjaro Evaluation
When exploring how to switch from Wegovy to Mounjaro, EverydayMeds streamlines the process with our comprehensive clinical assessment taking just three minutes online. Our prescribers review your medical history, current Wegovy experience, and reasons for considering Mounjaro within three working days (or 24 hours with express service). This assessment determines the most suitable treatment and appropriate starting dose, whether continuing Wegovy or transitioning to Mounjaro. Once approved, both medications arrive via next-day cold-chain delivery, maintaining the temperature-controlled storage essential for these biological therapies. Our GPhC-registered pharmacy (#9012878) ensures seamless supply for either treatment option throughout your monthly prescription cycle.
Storage and Practical Considerations When Switching Between Treatments
Both Wegovy and Mounjaro require refrigerated storage at 2-8°C, though Wegovy offers superior travel convenience with six weeks room temperature tolerance versus Mounjaro's 21-day limit. This storage advantage may influence monthly costs if you travel frequently, as Wegovy reduces the risk of medication waste due to temperature exposure. The FlexTouch pen delivery system for Wegovy provides consistent dosing across the monthly cycle, with clear dose escalation from 0.25mg through to the 2.4mg maintenance level. When considering how to switch from Wegovy to Mounjaro, these practical storage differences may impact your overall monthly medication management costs. Both treatments require the same injection frequency and storage infrastructure, minimising additional monthly expenses during any transition period.
Cost-Effectiveness Analysis: Long-Term Monthly Budgeting for Treatment Switches
Planning how to switch from Wegovy to Mounjaro requires careful monthly budget analysis beyond the immediate prescription costs. Wegovy's annual cost at maintenance dose (2.4mg) totals approximately £2,519.88, while Mounjaro's pricing structure may differ significantly. Factor in potential side effect management costs, as some patients switching between treatments may experience different tolerability profiles requiring additional healthcare support.
Consider the cost implications of treatment interruption when switching from Wegovy to Mounjaro, as any gap in therapy may affect your weight management progress. Our subscription model ensures consistent monthly delivery, reducing the administrative costs and time investment associated with frequent reordering. The DOSE25 discount for returning customers helps maintain competitive monthly pricing whether you continue Wegovy long-term or switch to Mounjaro after trial comparison.
Making Your Treatment Decision: Wegovy vs Mounjaro Monthly Investment
Both Wegovy and Mounjaro represent substantial monthly investments in your health, with costs justified by their clinical efficacy and convenience of once-weekly dosing. When determining how to switch from Wegovy to Mounjaro, consider that both medications are available from EverydayMeds with the same high-quality service standards. Our clinical team can help evaluate whether Mounjaro's dual-action mechanism justifies any cost difference compared to Wegovy's established GLP-1 approach. Use discount codes FIRST40 for new customers or DOSE25 for returning patients to access competitive pricing on either treatment. Visit https://everydaymeds.co.uk/collections/wegovy to begin your clinical assessment and receive expert guidance on the most cost-effective treatment option for your individual needs. Your prescriber can help determine which medication offers the best balance of clinical efficacy and monthly affordability for your weight management journey.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
